Literature DB >> 8761528

Variation in risk indicators of cardiovascular disease during the menstrual cycle: an investigation of within-subject variations in glutathione peroxidase, haemostatic variables, lipids and lipoproteins in healthy young women.

L F Larsen1, H R Andersen, A B Hansen, O Andersen.   

Abstract

Variations in erythrocyte glutathione peroxidase activity, serum concentrations of lipids and lipoproteins and in blood coagulation and fibrinolysis during the menstrual cycle were studied in healthy young women. Blood samples were drawn twice a week for 9 weeks. A group of males was used for estimation of the influence on the results of factors which were not related to the menstrual cycle. Variations during the menstrual cycle were demonstrated in several of the factors analysed. The activity of glutathione peroxidase was lowest at ovulation. The clotting activity of factor II+ VII+X and the concentration of fibrinogen were lowest during mid-cycle, and the number of platelets increased in the follicular phase (days 5-9). Statistically significant variations in the fibrinolytic factors analysed (tissue plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI) were not observed during the menstrual cycle. The serum concentrations of cholesterol and LDL cholesterol were significantly higher at the start of the menstrual cycle (days 3-8) than later in the cycle (days 19-24). The concentration of HDL cholesterol was lowest in the late luteal phase (days 23-28).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8761528     DOI: 10.3109/00365519609088613

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  7 in total

1.  A longitudinal study of serum lipoproteins in relation to endogenous reproductive hormones during the menstrual cycle: findings from the BioCycle study.

Authors:  Sunni L Mumford; Enrique F Schisterman; Anna Maria Siega-Riz; Richard W Browne; Audrey J Gaskins; Maurizio Trevisan; Anne Z Steiner; Julie L Daniels; Cuilin Zhang; Neil J Perkins; Jean Wactawski-Wende
Journal:  J Clin Endocrinol Metab       Date:  2010-06-09       Impact factor: 5.958

Review 2.  Failure to consider the menstrual cycle phase may cause misinterpretation of clinical and research findings of cardiometabolic biomarkers in premenopausal women.

Authors:  Enrique F Schisterman; Sunni L Mumford; Lindsey A Sjaarda
Journal:  Epidemiol Rev       Date:  2013-09-15       Impact factor: 6.222

3.  Variations in lipid levels according to menstrual cycle phase: clinical implications.

Authors:  Sunni L Mumford; Sonya Dasharathy; Anna Z Pollack; Enrique F Schisterman
Journal:  Clin Lipidol       Date:  2011-04-01

4.  Effect of Menstrual Cycle Phases on Plasma Lipid and Lipoprotein Levels in Regularly Menstruating Women.

Authors:  Shilpi Vashishta; Sushila Gahlot; Rajni Goyal
Journal:  J Clin Diagn Res       Date:  2017-05-01

5.  Ovarian Lipid Metabolism Modulates Circulating Lipids in Premenopausal Women.

Authors:  Jeffrey T Jensen; Ilana B Addis; Jon D Hennebold; Randy L Bogan
Journal:  J Clin Endocrinol Metab       Date:  2017-09-01       Impact factor: 5.958

Review 6.  Physiological changes during the menstrual cycle and their effects on the pharmacokinetics and pharmacodynamics of drugs.

Authors:  A D Kashuba; A N Nafziger
Journal:  Clin Pharmacokinet       Date:  1998-03       Impact factor: 6.447

7.  Intraoperative blood loss in female patients with adolescent idiopathic scoliosis during different phases of the menstrual cycle.

Authors:  Chao Li; Yang Xie; Zhikun Li; Mingyuan Yang; Xiaofei Sun; Jianping Fan; Honglei Yi Xiaodong Zhu; Chuanfeng Wang; Ming Li
Journal:  PLoS One       Date:  2014-11-25       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.